Communications
[7] A. E. Ambrose, J. W. William, J. Med. Chem. 2003, 44, 3849..
Reactions of Sulfonyl Chlorides with DABCO
1
2
3
4
5
6
7
8
[8] a) Y. A. Al-Soud, H. H. Al-Sa’doni, H. A. S. Amajaour, K. S. M. Salih, M. S.
Mubarak, N. A. Al-Masoudi, I. H. Z. Jaber, A. Naturforsch, Z. Naturforsch.,
B: Chem. Sci. 2008, 63, 83; b) C. J. Bungard, P. D. Williams, J. Schulz, C. M.
Wiscount, M. K. Holloway, H. M. Loughran, J. J. Manikowski, H.-P. Su,
D. J. Bennett, L. Chang, X.-J. Chu, A. Crespo, M. P. Dwyer, K. Keertikar,
G. J. Morriello, A. W. Stamford, S. T. Waddell, B. Zhong, B. Hu, T. Ji, T. L.
Diamond, C. Bahnck-Teets, S. S. Carroll, J. F. Fay, X. Min, W. Morris, J. E.
Ballard, M. D. Miller, J. A. McCauley, ACS Med. Chem. Lett. 2017, 8, 1292.
[9] D. C. Martyn, J. F. Cortese, E. Tyndall, J. Dick, R. Mazitschek, Bioorg. Med.
Chem. Lett. 2010, 20, 218.
To a dry 10 mL Schlenk-tube equipped with a stirring bar, DABCO
2 (2.0 mmol) in 3 mL of MeCN was added. After the solution was
°
heated to 90 C, sulfonyl chloride 1 (2.5 mmol) in MeCM (3.0 mL)
were added and the reaction mixtures were heated and stirred
under air for 4 hours. 1-(2-chloroethyl)-4-arylsulfonylpiperazines
were obtained after usual workup and purification on silica gel
column chromatography.
[10] K. P. Harish, K. N. Mohana, L. Mallesha, B. N. P. kumara, Eur. J. Med.
9
Manipulations on the 2-Chloroethyl Moiety of
1-(2-chloroethyl)-4-Tosylpiperazine 3a
Chem. 2013, 65, 276.
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
[11] a) G. Brook, Drugs Today 2000, 36, 125; b) A. M. Martel, A. Graul, X.
Rabasseda, R. Castaner, Drugs Futuree 1997, 22, 138; c) N. K. Terrett, A. S.
Bell, D. Brown, P. Ellis, Bioorg. Med. Chem. Lett. 1996, 6, 1819; d) M.
Boolell, M. J. Allen, S. A. Ballard, S. Gepi-Attee, G. J. Muirhead, A. M.
Naylor, I. H. Osterloh, C. Gingell, Int. J. Urol. Res. 1996, 8, 47.
[12] a) A. Aversa, M. Pili, D. Francomano, R. Bruzziches, E. Spera, G. La Pera,
G. Spera, Int. J. Impot. Res. 2009, 21, 221; b) J. S. Paick, T. Y. Ahn, H. K.
Choi, W. S. Chung, J. J. Kim, S. C. Kim, S. W. Kim, S. W. Lee, K. S. Min, K. H.
Moon, J. K. Park, K. Park, N. C. Park, J. K. Suh, D. Y. Yang, H. G. Jung, J.
Sex. Med. 2008, 5, 2672; c) L. A. Sorbera, L. Martin, J. Rabasseda, J.
Castaner, Drugs Future 2001, 26, 141.
To a dry 10 mL Schlenk-tube equipped with a stirring bar, 1-(2-
chloroethyl)-4-tosylpiperazine 3a (1.0 mmol), K2CO3 (3.0 mmol),
MeCN (4 mL), H2O (1.0 mL) and the corresponding nucleophile
(3.0 mmol) were added and the reaction mixtures were then
°
heated to 90 C for 4 hours. The desired 1-(2-substituted ethyl)-4-
arylsulfonylpiperazines were obtained after usual workup and
purification by silica gel column chromatography.
[13] J.-S. Paick, T. Y. Ahn, H. K. Choi, W.-S. Chung, J. J. Kim, S. C. Kim, S. W.
Kim, S. W. Lee, K. S. Min, K. H. Moon, J. K. Park, K. Park, N. C. Park, J.-K.
Suh, D. Y. Yang, H.-G. Jung, J. Sex. Med. 2008, 5, 2672.
Direct Conversion of DABCO into
N-Arylsulfonyl-4-(2-substituted ethyl)piperazines
[14] K. E. Gettys, Z. Ye, M. Dai, Synthesis 2017, 49, 2589.
To the reaction mixtures obtained from reaction of sulfonyl
chloride 1 (2.5 mmol) and DABCO (2.0 mmol) in MeCM (6.0 mL),
nucleophile Nu (6.0 mmol), water (2 mL) and K2CO3 (6.0 mmol)
were added and the reaction mixtures were heated and stirred
under air for another 4 hours. 1-(2-substituted ethyl)-4-arylsulfo-
nylpiperazines were obtained after usual workup and purification
by silica gel column chromatography.
[15] a) L. N. Yakhontov, L. B. Mrachkovskaya, Chem. Heterocycl. Compd. 1976,
12, 607; b) D. I. Bugaenko, Chem. Heterocycl. Compd. 2017, 53, 1277;
c) U. V.Mallavadhani, N. FleuryBregeot, 1,4-Diazabicyclo [2.2.2]octane. In
Encyclopedia of Reagents for Organic Synthesis, John Wiley & Sons, Ltd.
2010.
[16] J. Hartung, S. Hünig, R. Kneuer, M. Schwarz, H. Wenner, Synthesis 1997,
1997, 1433.
[17] D. Majee, S. Biswas, S. M. Mobin, S. Samanta, Org. Biomol. Chem. 2017,
15, 3286.
[18] X. Fang, J. Li, H.-Y. Tao, C.-J. Wang, Org. Lett. 2013, 15, 5554.
[19] a) J.-H. Li, J.-L. Li, D.-P. Wang, S.-F. Pi, Y.-X. Xie, M.-B. Zhang, X.-C. Hu, J.
Org. Chem. 2007, 72, 2053; b) J.-H. Li, W.-J. Liu, Org. Lett. 2004, 6, 2809;
c) J.-H. Li, W.-J. Liu, Y.-X. Xie, J. Org. Chem. 2005, 70, 5409.
[20] a) J. H. Li, X. D. Zhang, Y. X. Xie, Synthesis 2005, 804; b) J.-H. Li, Y. Liang,
Y.-X. Xie, J. Org. Chem. 2005, 70, 4393.
[21] J.-H. Li, Y. Liang, D.-P. Wang, W.-J. Liu, Y.-X. Xie, D.-L. Yin, J. Org. Chem.
Acknowledgements
The authors are grateful for financial support from the National
Natural Science Foundation of China (No. 21762040, 21762039
and 21262030).
2005, 70, 2832.
[22] A. Ying, Y. Ni, S. Xu, S. Liu, J. Yang, R. Li, Ind. Eng. Chem. Res. 2014, 53,
5678.
[23] a) S. D. Ross, M. Finkelstein, J. Am. Chem. Soc. 1963, 85, 2603; b) S. D.
Ross, J. J. Bruno, R. C. Petersen, J. Am. Chem. Soc. 1963, 85, 3999.
[24] For recent examples, see: a) N. Maras, S. Polanc, M. Kočevar, Org. Biomol.
Chem. 2012, 10, 1300; b) M. Koyioni, M. Manoli, P. A. Koutentis, J. Org.
Chem. 2016, 81, 615; c) M. Ghazanfarpour-Darjani, F. Barat-Seftejani, M.
Khalaj, S. M. Mousavi-Safavi, Helv. Chim. Acta 2017, 100, e1700082;
d) D. I. Bugaenko, M. A. Yurovskaya, A. V. Karchava, J. Org. Chem. 2017,
82, 2136; e) G. Min, J. Seo, H. M. Ko, J. Org. Chem. 2018, 83, 8417; f) Q.
Zhu, Q. Yuan, M. Chen, M. Guo, H. Huang, Angew. Chem. 2017, 129,
5183; Angew. Chem. Int. Ed. 2017, 56, 5101; g) Q. Zhu, M. Chen, J. Hu, L.
Yang, Chem. Asian J. 2018, 13, 1124; h) H.-J. Wang, Y. Wang, A. J. Csakai,
W. G. Earley, R. J. Herr, J. Comb. Chem. 2009, 11, 355; i) D. I. Bugaenko,
M. A. Yurovskaya, A. V. Karchava, Org. Lett. 2018, 20, 6389.
[25] a) N. Maras, S. Polanc, M. Kočevar, Org. Biomol. Chem. 2012, 10, 1300;
b) I. Yavari, M. J. Bayat, M. Ghazanfarpour-Darjani, Tetrahedron Lett.
2014, 55, 5595.
Conflict of Interest
The authors declare no conflict of interest.
Keywords: charge-transfer complex
DABCO · Sulfonamides · piperazine
· sulfonyl chloride ·
[1] a) M. E. Welsch, S. A. Snyder, B. R. Stckwell, Curr. Opin. Chem. Biol. 2010,
14, 347; b) E. Vitaku, D. T. Smith, J. T. Njardarson, J. Med. Chem. 2014, 57,
10257; c) M. Feng, B. Tang, S. H. Liang, X. Jiang, Curr. Top. Med. Chem.
2016, 16, 1200.
[2] a) E. A. Amin, W. J. Welsh, J. Med. Chem. 2001, 44, 3849; b) M. Cheng, B.
De, S. Pikul, N. G. Almstead, M. G. Natchus, M. V. Anastasio, S. J. McPhail,
C. E. Snider, Y. O. Taiwo, L. Chen, C. M. Dunaway, F. Gu, M. E. Dowty,
G. E. Mieling, M. J. Janusz, S. Wang-Weigand, J. Med. Chem. 2000, 43,
369.
[26] J. R. Gandler, I. U. Setiarahardjo, C. Tufon, C. Chen, J. Org. Chem. 1992,
57, 4169.
[27] a) M. Koyioni, M. Manoli, P. A. Koutentis, J. Org. Chem. 2016, 81, 615;
b) S. G. Gladstone, W. G. Earley, J. K. Acker, G. S. Martin, Tetrahedron Lett.
2009, 50, 3813; c) H.-J. Wang, W. G. Earley, R. M. Lewis, R. R. Srivastava,
A. J. Zych, D. M. Jenkins, D. J. Fairfax, Tetrahedron Lett. 2007, 48, 3043.
[28] G. Min, J. Seo, H. Min Ko, J. Org. Chem. 2018, 83, 8417.
[29] D. I. Bugaenko, M. A. Yurovskaya, A. V. Karchava, J. Org. Chem. 2017, 82,
2136.
[3] M. K. Parai, G. Panda, K. Srivastava, S. K, Puri, Bioorg. Med. Chem. Lett.
2008, 18, 776.
[4] T. A. Shahrukh, C. P. Keshav, Indian J. Chem. Sect. B 2010, 49, 960.
[5] C. S. A. Kumar, S. N. Swamy, N. R. Thimmegowda, S. B. B. Prasad, G. W.
Yip, K. S. Rangappa, Med. Chem. Res. 2007, 16, 179.
[30] a) C. R. Treadway, M. G. Hill, J. K. Barton, Chem. Phys. 2002, 281, 409;
b) R. S. Mulliken, J. Phys. Chem. 1952, 56, 801; c) H. Yu, B. Gao, B. Hu, H.
[6] S. Saingar, R. Kumar, Y. C. Joshi, Med. Chem. Res. 2011, 20, 975.
ChemistryOpen 2019, 8, 127–131
130
© 2019 The Authors. Published by Wiley-VCH Verlag GmbH & Co. KGaA